UnitedHealth Group Incorporated (NYSE:UNH) Stake Cut by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 484,358 shares of the healthcare conglomerate’s stock after selling 3,571 shares during the quarter. UnitedHealth Group makes up 0.8% of Asset Management One Co. Ltd.’s portfolio, making the stock its 16th biggest position. Asset Management One Co. Ltd. owned approximately 0.05% of UnitedHealth Group worth $247,003,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the 3rd quarter worth $37,000. Friedenthal Financial acquired a new position in shares of UnitedHealth Group during the third quarter valued at $51,000. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $57,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.7 %

Shares of UNH opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s 50-day moving average price is $524.58 and its 200 day moving average price is $563.71. The stock has a market capitalization of $488.95 billion, a P/E ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on UNH. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.